Alzheimer’s disease (AD) is characterized by the formation of large, insoluble deposits, or plaques, of amyloid-β peptide (Aβ) in the brain. These plaques are generated by the aggregation of smaller, soluble clumps made up of perhaps a dozen or so Aβ monomers. Recent research indicates that it is these smaller Aβ aggregates, or oligomers, and […]
The post Alzheimer’s Disease Toxicity Halted by Synthetic Peptides appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Article: Alzheimer’s Disease Toxicity Halted by Synthetic Peptides